Intratumoral administration of unconjugated Accum™ impairs the growth of pre‐established solid lymphoma tumors
JP Bikorimana, N El‐Hachem, M Moreau… - Cancer …, 2023 - Wiley Online Library
The Accum™ technology was initially designed to enhance the bioaccumulation of a given
molecule in target cells. It does so by triggering endosomal membrane damages allowing …
molecule in target cells. It does so by triggering endosomal membrane damages allowing …